The Digital Medicine Society (DiMe) announced today a new collaboration with Acclinate, Amgen, GSK, Lightship, Medable, Rubix LS, Sage Bionetworks, Savvy Cooperative, and THREAD Research to drive inclusion in digital clinical trials. The initiative aims to provide the tools and framework necessary to successfully integrate diverse perspectives during the planning process for trials that include a technology device for participation.
Everywhere we turn, we’re being nudged toward doing more, faster. Whether it's productivity hacks on LinkedIn or the growing influence of AI in both o...
At Acclinate, we’re committed to fostering the next generation of health equity champions. That’s why we launched the Acclinate Health Equity Scholars...
Personalized medicine is transforming healthcare by tailoring treatments to the unique genetic and environmental makeup of each patient. But without e...
Clinical research often compartmentalizes equity in one bucket, efficiency in another. Representation is framed as a moral imperative. Budget and time...
At first glance, data looks objective—numbers, percentages, trends. But behind every data point is a real person, living in a real community, navigati...
Key Takeaways and Learnings As advanced data analytics and AI take hold in healthcare, sponsors shouldn’t overlook the potential to predict who will e...
Key Takeaways and Learnings Community engagement is critical to improving health equity, but it has to start long before sponsors recruit patients for...
When we talk about disparities in healthcare, we often focus on patient access—who gets invited to participate in clinical trials or who receives care...
